Qube Research & Technologies (QRT)
MCRB icon

Qube Research & Technologies (QRT)’s Seres Therapeutics MCRB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-875
Closed -$16.5K – 3689
2024
Q3 		$16.5K Buy
+875
New +$17.8K ﹤0.01% 2988
2024
Q1 		– Sell
-32,033
Closed -$897K – 4711
2023
Q4 		$897K Buy
32,033
+23,756
+287% +$624K ﹤0.01% 1985
2023
Q3 		$394K Buy
+8,277
New +$632K ﹤0.01% 2127
2022
Q3 		– Sell
-1,623
Closed -$111K – 2803
2022
Q2 		$111K Buy
1,623
+884
+120% +$76.2K ﹤0.01% 1905
2022
Q1 		$105K Sell
739
-6,497
-90% -$999K ﹤0.01% 2066
2021
Q4 		$1.21M Buy
+7,236
New +$1.15M 0.01% 1081

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MCRB Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Seres Therapeutics (MCRB) in Q4 2024, closing a stake of 875 shares — an estimated $16.5K sold.

Qube Research & Technologies (QRT) first reported a position in MCRB in Q4 2021 and held it in 6 quarters. The position peaked at $1.21M in Q4 2021. 69 funds tracked by Wall St. Rank hold MCRB as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Seres Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 875 Seres Therapeutics shares in Q4 2024, an estimated $16.5K.
  • Qube Research & Technologies (QRT) first reported a position in Seres Therapeutics in Q4 2021 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Seres Therapeutics position peaked at $1.21M in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.